Revance Releases Second Quarter 2018 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Revance Releases Second Quarter 2018 Results

Revance Therapeutics (RVNC) Reports In-Line Q2 EPS

August 2, 2018 5:08 PM EDT

Revance Therapeutics (NASDAQ: RVNC) reported Q2 EPS of ($0.94), in-line with the analyst estimate of ($0.94). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $510 thousand.

GUIDANCE:

Revance reiterates its financial guidance provided in January 2018.... More